In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abgenix nets $496.5mm in follow-on offering

Executive Summary

Netting a total of $496.5mm, antibody therapeutics company Abgenix completed a follow-on public offering of 2.48mm common shares at $210 apiece, including a 324k share overallotment. The company filed in January for the offering, and at that time was trading at a price of about $158.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies